Genetic Testing for Fertility: Early Detection of Inherited Causes of Infertility
Manar Hegazy
Majd Eddin Khaled
Genetic fertility testing helps identify inherited or chromosomal causes that may contribute to infertility, severe sperm abnormalities, azoospermia, recurrent miscarriage, early ovarian insufficiency, or the risk of passing a genetic disease to a child. These tests can guide decisions such as ICSI, sperm retrieval, embryo genetic testing, or genetic counseling. However, genetic testing should be targeted; it is not a routine list for every couple trying to conceive.
What genetic fertility testing means
Genetic fertility testing may examine chromosomes, specific genes, or carrier status for inherited diseases. Examples include karyotype testing, Y-chromosome microdeletion testing, CFTR testing, FMR1 testing, and carrier screening. The correct test depends on the couple’s history, semen analysis, ovarian reserve, miscarriage history, and family background.
Does genetic testing always find the cause?
No. Many infertility cases are not explained by genetic testing. Tubal blockage, ovulation disorders, uterine disease, varicocele, age, inflammation, and egg quality can still be the main causes. Genetic testing is most useful when it answers a specific clinical question.
When genetic testing becomes important
Genetic testing becomes more important in azoospermia, severe oligozoospermia, congenital absence of the vas deferens, premature ovarian insufficiency, recurrent pregnancy loss, known inherited disease, consanguinity, or a strong family history. In these cases, results may change treatment planning.
Genetic Tests for Severe Male Infertility
In men, genetic testing is especially relevant when semen analysis shows no sperm or very low sperm concentration. Some genetic causes do not affect general appearance or health but may strongly affect sperm production or sperm transport.
Male karyotype testing
Karyotype testing evaluates the number and structure of chromosomes. It may be recommended in men with primary infertility and azoospermia or severe oligozoospermia, especially when impaired sperm production is suspected. A chromosomal finding may affect counseling, ICSI planning, and embryo testing decisions.
Y-chromosome microdeletion testing
Y-chromosome microdeletion testing looks for missing regions involved in sperm production. The result can help estimate sperm retrieval chances in selected azoospermia cases and may also raise counseling issues because some deletions can be passed to male offspring through ICSI.
CFTR testing in suspected congenital obstruction
CFTR testing is important when there is congenital absence of the vas deferens or idiopathic obstructive azoospermia. In this setting, sperm production may be present, but sperm cannot reach the ejaculate. If a CFTR variant is found in the male partner, testing the female partner may be needed to assess the child’s inherited disease risk.
Genetic Testing in Women With Low Ovarian Reserve or Early Ovarian Insufficiency
In women, genetic testing is not needed for every infertility case, but it becomes important when ovarian function is reduced at a young age, periods stop early, or there is a family history of premature ovarian insufficiency.
Female karyotype testing
Karyotype testing may be considered when a chromosomal condition is suspected or when recurrent pregnancy loss suggests a parental structural rearrangement. A person may be healthy while carrying a balanced rearrangement, but embryos may inherit an unbalanced form that can lead to miscarriage or failed pregnancy.
FMR1 testing in premature ovarian insufficiency
FMR1 premutation testing is recommended in non-iatrogenic premature ovarian insufficiency. A positive result can affect fertility planning and family counseling, because it may have implications for relatives and future children.
Does a genetic result mean pregnancy is impossible?
No. A genetic finding does not always mean pregnancy is impossible. It helps define the safest and most realistic plan, which may include IVF with PGT, faster fertility preservation decisions, family counseling, or targeted reproductive planning.
Read about: AMH Test and Ovarian Reserve: What Your Results Really Mean
Carrier Screening Before Pregnancy and IVF
Carrier screening identifies whether one or both partners carry variants for inherited conditions that may affect a child. Carriers are usually healthy and may not know they carry a condition. Screening can be especially useful before pregnancy or IVF when there is family history, consanguinity, or a known inherited disorder.
What is carrier screening?
Carrier screening tests whether a person carries gene variants for inherited conditions such as cystic fibrosis, spinal muscular atrophy, hemoglobinopathies, or broader panels depending on the situation. If one partner is a carrier, the other partner may be tested for the same condition.
Why testing before pregnancy is useful
Testing before pregnancy gives the couple time to understand risk, receive genetic counseling, and discuss options such as natural conception with prenatal testing or IVF with PGT-M when appropriate. Finding risk only after pregnancy has started may make decisions more difficult.
Is expanded carrier screening for everyone?
Expanded carrier screening may be useful, but it requires careful counseling. It can reveal carrier status for conditions that do not affect the adult carrier but may affect children if both partners carry the same condition. The test should be linked to a clear plan.
Genetic Tests in Recurrent Miscarriage and Failed IVF Attempts
Recurrent miscarriage and failed IVF attempts can have many causes, including embryo chromosome abnormalities, age-related egg factors, uterine disease, hormones, immune factors, or sperm factors. Genetic testing is most helpful when results can guide the next step.
Couple karyotype in recurrent pregnancy loss
In recurrent pregnancy loss, parental karyotype testing may identify balanced chromosomal rearrangements. The carrier may be healthy, but embryos can inherit unbalanced chromosomes, leading to miscarriage or failed pregnancy. This may lead to discussion of PGT-SR in IVF.
Testing pregnancy tissue after miscarriage
When available, testing miscarriage tissue may show whether the loss was caused by an embryo chromosome abnormality. This can help distinguish a random embryo event from a repeated pattern that needs additional couple testing.
When genetic testing connects to PGT
If a couple carries a known monogenic condition or a structural chromosome rearrangement, PGT may be used during IVF to test embryos before transfer. PGT does not create healthy embryos or guarantee pregnancy, but it helps select embryos more appropriately when the genetic risk is known.
Read about: Thyroid Antibody Testing Effects on Fertility and Pregnancy
Fertiliv’s Approach to Genetic Fertility Testing
At Fertiliv, genetic testing is selected according to the couple’s history and test results. The goal is not to order every possible test, but to identify the tests that can change the treatment plan.
Couple-based assessment before testing
The plan begins with semen analysis, hormone evaluation, ultrasound, ovarian reserve testing, miscarriage history, previous children, family history, and any known inherited disease. Genetic tests are then chosen based on clear indications.
Connecting results to treatment decisions
A Y-chromosome deletion may affect sperm retrieval counseling. A CFTR finding may require partner testing. A structural chromosome rearrangement may lead to PGT-SR. A shared inherited disease may lead to PGT-M. Each result should produce a practical decision, not just more confusion.
Genetic counseling before and after testing
Genetic counseling helps couples understand inheritance risk, test limits, uncertain results, and reproductive options. It is especially important before expanded carrier screening, PGT-M, PGT-SR, or testing related to premature ovarian insufficiency.
Read about: Autoimmune Tests And Their Effect On Implantation: When Should They Be Done?
Conclusion
Genetic fertility tests can identify important inherited causes of infertility, including chromosomal abnormalities, Y-chromosome microdeletions, CFTR-related obstruction, FMR1-related ovarian insufficiency, and shared carrier risks. They are not needed for every couple, but they are valuable when targeted to the right clinical situation and linked to a clear treatment plan such as ICSI, Micro-TESE, PGT-M, PGT-SR, or family counseling.
Frequently Asked Questions: Genetic Fertility Testing
Is genetic testing needed for every infertility case?
No. It is mainly used when there are clinical indicators such as azoospermia, severe sperm abnormalities, recurrent miscarriage, early ovarian insufficiency, or inherited disease risk.
What are the main genetic tests for male infertility?
They may include karyotype, Y-chromosome microdeletion testing, and CFTR testing depending on the semen analysis and clinical findings.
When is FMR1 testing used in women?
FMR1 testing is considered in non-iatrogenic premature ovarian insufficiency because it may affect fertility and family genetic counseling.
How is genetic testing related to PGT?
If a genetic condition or chromosomal rearrangement is identified, embryos can sometimes be tested during IVF before transfer.
Does a normal genetic test rule out all genetic causes?
No. It reduces the likelihood of the tested conditions but does not exclude all genetic or non-genetic causes of infertility.